Coyne Terrance P. 内部人交易:近期 SEC Form 4 交易
过去 18 个月,Coyne Terrance P.(CIK 1814876)在 1 家公司共报告 48 笔 SEC Form 4 内部人交易(最近一笔 2026-11-18)。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 135,249 | $9.3M |
| 2026-11-18 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 14,751 | $1.0M |
| 2026-11-18 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 90,165 | $6.2M |
| 2026-11-18 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 9,835 | $671,777 |
| 2026-11-18 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 7,122 | $490,478 |
| 2026-11-06 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 7,122 | $0 |
| 2026-11-06 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 150,000 | $0 |
| 2026-11-06 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 100,000 | $0 |
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 9,230 | $540,786 |
| 2026-08-17 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,772 | $104,796 |
| 2026-08-07 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 11,002 | $0 |
| 2026-05-28 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 64,399 | $3.5M |
| 2026-05-08 | Royalty Pharma plc (RPRX) | EVP & CFO | 买入 | 24,263 | $0 |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $93,338 |
| 2026-04-30 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.6M |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $90,619 |
| 2026-04-02 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.6M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.5M |
| 2026-03-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $85,369 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 22,487 | $1.0M |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 10,429 | $490,267 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,292 | $60,298 |
| 2026-03-04 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 583 | $27,407 |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 32,916 | $1.5M |
| 2026-02-25 | Royalty Pharma plc (RPRX) | EVP & CFO | 卖出 | 1,875 | $84,975 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18